Heterogeneity in the Effectiveness of Non-pharmaceutical Interventions During the First SARS-CoV2 Wave in the United States

被引:6
|
作者
Pan, William K. [1 ,2 ]
Fernandez, Daniel [3 ,4 ]
Tyrovolas, Stefanos [5 ,6 ,7 ]
Iago, Gine-Vazquez [6 ,7 ]
Dasgupta, Rishav Raj [2 ]
Zaitchik, Benjamin F. [8 ]
Lantos, Paul M. [2 ,9 ]
Woods, Christopher W. [2 ,9 ]
机构
[1] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA
[2] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA
[3] Polytech Universitat Politecn Catalunya Barcelona, Dept Stat & Operat Res, Barcelona, Spain
[4] Inst Math UPC BarcelonaTech IMTech, Barcelona, Spain
[5] Hong Kong Polytech Univ, WHO Collaborating Ctr Community Hlth Serv WHOCC, Sch Nursing, Hong Kong, Peoples R China
[6] Univ Barcelona, Parc Sanitari St Joan de Deu, Fundacio St Joan de Deu, Barcelona, Spain
[7] Ctr Invest Biomed Red Salud Mental CIBERSAM, Inst Salud Carlos III, Madrid, Spain
[8] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA
[9] Duke Univ, Duke Sch Med, Durham, NC USA
关键词
SARS-CoV-2; non-pharmaceutical intervention (NPI); doubling time; mortality rate; United States; AIRBORNE TRANSMISSION; COVID-19; OUTBREAKS; CORONAVIRUS;
D O I
10.3389/fpubh.2021.754696
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Attempts to quantify effect sizes of non-pharmaceutical interventions (NPI) to control COVID-19 in the US have not accounted for heterogeneity in social or environmental factors that may influence NPI effectiveness. This study quantifies national and sub-national effect sizes of NPIs during the early months of the pandemic in the US.Methods: Daily county-level COVID-19 cases and deaths during the first wave (January 2020 through phased removal of interventions) were obtained. County-level cases, doubling times, and death rates were compared to four increasingly restrictive NPI levels. Socio-demographic, climate and mobility factors were analyzed to explain and evaluate NPI heterogeneity, with mobility used to approximate NPI compliance. Analyses were conducted separately for the US and for each Census regions (Pacific, Mountain, east/West North Central, East/West South Central, South Atlantic, Middle Atlantic and New England). A stepped-wedge cluster-randomized trial analysis was used, leveraging the phased implementation of policies.Results: Aggressive (level 4) NPIs were associated with slower COVID-19 propagation, particularly in high compliance counties. Longer duration of level 4 NPIs was associated with lower case rates (log beta -0.028, 95% CI -0.04 to -0.02) and longer doubling times (log beta 0.02, 95% CI 0.01-0.03). Effects varied by Census region, for example, level 4 effects on doubling time in Pacific states were opposite to those in Middle Atlantic and New England states. NPI heterogeneity can be explained by differential timing of policy initiation and by variable socio-demographic county characteristics that predict compliance, particularly poverty and racial/ethnic population. Climate exhibits relatively consistent relationships across Census regions, for example, higher minimum temperature and specific humidity were associated with lower doubling times and higher death rates for this period of analysis in South Central, South Atlantic, Middle Atlantic, and New England states.Conclusion and Relevance: Heterogeneity exists in both the effectiveness of NPIs across US Census regions and policy compliance. This county-level variability indicates that control strategies are best designed at community-levels where policies can be tuned based on knowledge of local disparities and compliance with public health ordinances.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Effectiveness of non-pharmaceutical interventions as implemented in the UK during the COVID-19 pandemic: a rapid review
    Ashcroft, T.
    Mcswiggan, E.
    Agyei-Manu, E.
    Nundy, M.
    Atkins, N.
    Kirkwood, J. R.
    Machiri, M. Ben Salem
    Vardhan, V.
    Lee, B.
    Kubat, E.
    Ravishankar, S.
    Krishan, P.
    De Silva, U.
    Iyahen, E. O.
    Rostron, J.
    Zawiejska, A.
    Ogarrio, K.
    Harikar, M.
    Chishty, S.
    Mureyi, D.
    Evans, B.
    Duval, D.
    Carville, S.
    Brini, S.
    Hill, J.
    Qureshi, M.
    Simmons, Z.
    Lyell, I
    Kavoi, T.
    Dozier, M.
    Curry, G.
    Ordonez-Mena, J. M.
    de Lusignan, S.
    Sheikh, A.
    Theodoratou, E.
    Mcquillan, R.
    JOURNAL OF PUBLIC HEALTH, 2025,
  • [42] Modelling COVID-19 transmission dynamics in Laos under non-pharmaceutical interventions, vaccination, and replacement of SARS-CoV-2 variants
    Xu-Sheng Zhang
    Hong Luo
    Andre Charlett
    Daniela DeAngelis
    Wei Liu
    Peter Vickerman
    Mark Woolhouse
    Linxiong Wu
    BMC Global and Public Health, 2 (1):
  • [43] New evidence on the health and employment effects of non-pharmaceutical COVID-19 interventions on workers in the United States
    Aksu, Ege
    De, Prabal K.
    Timilsina, Laxman
    EMPIRICAL ECONOMICS, 2024, 67 (06) : 2771 - 2819
  • [44] Descriptive and retrospective analysis of diffuse glioma patients with symptomatic SARS-CoV2 infection during the first wave of the pandemic
    Lozano-Sanchez, Fernando
    Ursu, Renata
    Di-Stefano, Anna Luisa
    Ducray, Francois
    Younan, Nadia
    Touat, Mehdi
    Groh, Matthieu
    Agguini, Hanane
    Belin, Catherine
    Garnier, Luois
    Delattre, Jean-Yves
    Carpentier, Antoine
    Idbaih, Ahmed
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [45] Macro-level drivers of SARS-CoV-2 transmission: A data-driven analysis of factors contributing to epidemic growth during the first wave of outbreaks in the United States
    Watts, Matthew J.
    SPATIAL AND SPATIO-TEMPORAL EPIDEMIOLOGY, 2022, 43
  • [46] Association of Non-Pharmaceutical Interventions to Reduce the Spread of SARS-CoV-2 With Anxiety and Depressive Symptoms: A Multi-National Study of 43 Countries
    Riehm, Kira E.
    Badillo Goicoechea, Elena
    Wang, Frances M.
    Kim, Esther
    Aldridge, Luke R.
    Lupton-Smith, Carly P.
    Presskreischer, Rachel
    Chang, Ting-Hsuan
    LaRocca, Sarah
    Kreuter, Frauke
    Stuart, Elizabeth A.
    INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 2022, 67
  • [47] Assessing the impact of non-pharmaceutical interventions (NPIs) and BCG vaccine cross-protection in the transmission dynamics of SARS-CoV-2 in eastern Africa
    Kilonzo, Chelsea Mbeke
    Wamalwa, Mark
    Whegang, Solange Youdom
    Tonnang, Henri E. Z.
    BMC RESEARCH NOTES, 2022, 15 (01)
  • [48] Assessing the impact of non-pharmaceutical interventions (NPIs) and BCG vaccine cross-protection in the transmission dynamics of SARS-CoV-2 in eastern Africa
    Chelsea Mbeke Kilonzo
    Mark Wamalwa
    Solange Youdom Whegang
    Henri E. Z. Tonnang
    BMC Research Notes, 15
  • [49] Significant relaxation of SARS-CoV-2-targeted non-pharmaceutical interventions may result in profound mortality: A New York state modelling study
    Hoffman, Benjamin U.
    PLOS ONE, 2020, 15 (09):
  • [50] Factors Related to Non-compliance With Non-pharmaceutical Interventions to Mitigate the Spread of SARS-CoV-2: Results From a Survey in the Swiss General Adult Population
    Hengartner, Michael P.
    Waller, Gregor
    von Wyl, Agnes
    FRONTIERS IN PUBLIC HEALTH, 2022, 10